4.5 Article

High-yield secretion of recombinant proteins expressed in tobacco cell culture with a designer glycopeptide tag: Process development

Journal

BIOTECHNOLOGY JOURNAL
Volume 11, Issue 4, Pages 497-506

Publisher

WILEY-V C H VERLAG GMBH
DOI: 10.1002/biot.201500377

Keywords

Bioreactor; Hydroxyproline-O-glycosylation; Perfusion culture; Plant cell culture; Recombinant protein

Funding

  1. Arkansas Center for Plant-Powered Production through NSF RII Arkansas ASSET Initiative [EPS-1003970]
  2. National Institute of Health (NIH) [1R43GM093621-01]
  3. Arkansas Biosciences Institute, Arkansas Tobacco Settlement Proceeds Act
  4. Office Of The Director
  5. EPSCoR [1003970] Funding Source: National Science Foundation

Ask authors/readers for more resources

Low-yield protein production remains the most significant economic hurdle with plant cell culture technology. Fusions of recombinant proteins with hydroxyproline-O-glycosylated designer glycopeptide tags have consistently boosted secreted protein yields. This prompted us to study the process development of this technology aiming to achieve productivity levels necessary for commercial viability. We used a tobacco BY-2 cell culture expressing EGFP as fusion with a glycopeptide tag comprised of 32 repeat of Ser-Pro dipeptide, or (SP)(32), to study cell growth and protein secretion, culture scale-up, and establishment of perfusion cultures for continuous production. The BY-2 cells accumulated low levels of cell biomass (approximate to 7.5 g DW/L) in Schenk & Hildebrandt medium, but secreted high yields of (SP)(32)-tagged EGFP (125 mg/L). Protein productivity of the cell culture has been stable for 6.0 years. The BY-2 cells cultured in a 5-L bioreactor similarly produced high secreted protein yield at 131 mg/L. Successful operation of a cell perfusion culture for 30 days was achieved under the perfusion rate of 0.25 and 0.5 day(-1), generating a protein volumetric productivity of 17.6 and 28.9 mg/day/L, respectively. This research demonstrates the great potential of the designer glycopeptide technology for use in commercial production of valuable proteins with plant cell cultures.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available